Quick Takeaways
- AdvisorShares Trust filed SCHEDULE 13G for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB).
- Disclosed ownership: 6.3%.
- Date of event: 30 Sep 2025.
AdvisorShares Trust - 30 Sep 2025 SCHEDULE 13G Report for Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB)
- Filing Manager
- AdvisorShares Trust
- Reporting Manager
- AdvisorShares Trust
- Symbol
- ENVB
- Shares outstanding
- 3,248,469 shares
- Disclosed Ownership
- 203,679 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Oct 2025, 17:51:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 02 Apr 2025
- Next filing
- 05 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"AdvisorShares Trust disclosed 6.3% ownership in Enveric Biosciences, Inc. Common Stock, $0.01 par value (ENVB) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 02 Apr 2025.
- Current filing was accepted on 03 Oct 2025, 17:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AdvisorShares Trust | 6.3% | 203,679 | 203,679 | 0 | /s/ Stefanie Little | Stefanie Little - Chief Compliance Officer |